Experienced in Bronchitis

Axel M. Schafer

Goettingen, NI, DE 
Experienced in Bronchitis
Goettingen, NI, DE 
OverviewLocationsClinical Research

Overview

Axel Schafer practices in Goettingen, Germany. Schafer is rated as an Experienced expert by MediFind in the treatment of Bronchitis. Their top areas of expertise are Schizophrenia, Chronic Pain, Bronchitis, Headache, and Thrombectomy.

Their clinical research consists of co-authoring 87 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Bronchitis.

Locations

Goettingen, NI 37075, Germany
Other Locations
Marburg An Der Lahn, HE, Germany
Hildesheim, NI 31134, Germany
Berlin, BE, Germany
Recklinghausen, NW, Germany
Giessen, HE, Germany
Essen, NW, Germany
Mannheim, BW, Germany
Degree Course Speech And Language Therapy And Physiotherapy, Bremen, HB, Germany
BG Clinic Ludwigshafen, Ludwig Guttmann Str. 13, Ludwigshafen Am Rhein, RP 67071, Germany
Homburg, SL 66421, Germany
Filderstadt, BW 70794, Germany
Bochum, NW 44801, Germany
Witten, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
View 2 Less Clinical Trials

87 Total Publications

Brain Aging in Specific Phobia: An ENIGMA-Anxiety Mega-Analysis.
Brain Aging in Specific Phobia: An ENIGMA-Anxiety Mega-Analysis.
Journal: medRxiv : the preprint server for health sciences
Published: April 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schafer's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile